Fig. 7From: RhoA enhances osteosarcoma resistance to MPPa-PDT via the Hippo/YAP signaling pathwayThe potential mechanisms of RhoA-mediated MPPa-PDT resistance in OS. The mevalonate pathway activates RhoA, in turn leading to YAP activation and MPPa-PDT resistance in OS cellsBack to article page